GPCR antagonists are compounds that bind to GPCRs and inhibit their activity, blocking the signal transduction pathways that promote cancer cell proliferation and survival. By preventing the activation of these receptors, antagonists can reduce tumor growth and metastasis. They achieve this by interfering with the binding of natural ligands or by inducing a conformational change that prevents receptor activation.
